GOTHENBURG, Sweden , July 18, 2024 /PRNewswire/ -- "Net sales increased by 15.7% in the second quarter, of which the organic increase was 8.9%," says Mattias Perjos, President & CEO at Getinge. "The operating margin improved compared with last year due to strong sales and a positive product mix, which supports a solid financial position that enables investments in profitable growth." Getinge's order intake increased by 14.4%, of which organic growth was 7.8% due to positive performance in all business areas. Investments in the product portfolio is a fundamental piece of the medtech company's strategy and during the quarter numerous important new products were launched. "One of these was Poladus 150, an advanced low-temperature sterilizer that meets a significant need for our customers. From a regulatory perspective, we received a 510(k) clearance for Talis innovative software, which offers digital clinical decision support, and our Advanta V12 covered stent system received EU MDR approval. Life Science launched the GEW 888 neo washer that increases cleanroom efficiency and helps reduce water consumption by 20%. In addition, a new version of the DPTE-BetaBag® was launched. This new version is made of plastic from renewable sources, which reduces the carbon footprint of the bag without compromising its sterile transfer capabilities," says Mattias Perjos, President & CEO at Getinge. On May 8, the FDA sent a letter to healthcare providers in the US relating to the Cardiosave intra-aortic balloon pump and the Cardiohelp ECLS system. The letter did not refer to any new field actions, but users were recommended to change to ...